Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with FOLFIRI or FOLFOX in Untreated Metastatic Colorectal Cancer
NCT00077233Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2003
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by Cancer and Leukemia Group B. Started Dec 2003; status: terminated.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00077233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077233.